forgot link Here it is :
Celldex Therapeutics: Breakthrough Drugs At A Bargain Price
Feb 26 2013, 13:23 | about: CLDX
By: Jonathan Faison
Disclosure: I am long CLDX. (More...)
Celldex Therapeutics (CLDX), even after the recent run up in share price, presents one of the few values left in an overbought market. With around 80 million shares outstanding, the present market cap of near $700 million is a bargain that will not last much longer as the rest of Wall Street finally catches on.
Over the past year, I've seen daily trading volume move up steadily to over a million shares, in addition to increased coverage from Wall Street analysts with an average price
target of $12. All signs are bullish